Two immunotherapy drugs currently approved by the US Food and Drug Administration (FDA) for the treatment of melanoma also show promise for treating a rare but aggressive form of papillary thyroid cancer, according to new research.
Two immunotherapy drugs currently approved by the US Food and Drug Administration (FDA) for the treatment of melanoma also show promise for treating a rare but aggressive form of papillary thyroid cancer, according to new research.